For individuals with migraine frequency of 4 to 14 episodes per month, prophylactic medications and analgesics are required.
Benefits of migraine markers include facilitating diagnosis, monitoring treatment, and discovering more about the pathogenesis of the disorder.
Research on therapies that may rouse a patient in a persistent vegetative state needs to include the ethical considerations of waking a patient in a state of incomplete recovery.
Anesthetic medications have been identified as a potential cause of morbidity in this population due to their interaction with the drugs used to manage Parkinson disease.
Conflict-of-interest statements should be included in medical journals in order to enhance transparency.
Headache screening should be a routine part of a prenatal visit so that if and when a patient presents with an attack, a suitable plan of action is already established.
Because of dementia's prolonged disease course, advance care decisions and planning are often overlooked until it is too late.
Treating Tension-Type Headache: Contradictions in Real-Life vs Research Expose Cracks in Differential Diagnosis
While there is some moderate quality evidence supporting the use of onabotulinumtoxinA for the treatment of tension-type headache, it is not adequate enough to influence current clinical practice.
This clinician discusses the application of conscious vs unconscious thinking in a medical practice.
Increasing evidence suggests a relationship between migraine and MS that is beyond basic comorbidity.
There is a growing emphasis on provider responsibility with the increasing focus of the overprescribing of opioids.
Interventions aimed at motor and cognitive impairments in Huntington disease may result in long-term functional improvement.
The judicious use of caffeine as adjuvant therapy to over-the-counter pain relievers can improve or relieve pain for patients with migraine or tension-type headaches.
The automated diagnosis suggestion at the top of the EKG strip is the output of what is known as a decision support system.
The scourge of defensive medicine — the practice of recommending tests or treatments for the purpose of avoiding or mitigating litigation — is discussed in this opinion piece.
Several studies have uncovered sex-dependent variations in the symptomatic manifestations of Parkinson disease, as well as in the response to dopamine therapies.
Depression is one of the most commonly reported complications resulting from stroke.
Throughout the life course, higher body mass index and obesity are linked to cognitive decline, brain atrophy, reduced white matter and integrity of the blood-brain barrier, and elevated risk for late-onset Alzheimer disease.
The 2017 revision takes aim at better differentiating relapsing-remitting and primary-progressive forms of multiple sclerosis.
Chronic pain is common after traumatic brain injury.
The responsibility for discussing cessation of driving in patients with mild cognitive impairment or dementia often rests on the clinician, who may have little preparation for this difficult conversation.
Numerous factors are likely contribute to the rate of progression, with different combinations of factors showing relevance for individual patients.
Although pharmacotherapy remains the standard strategy for migraine management, there are many patients for whom nonpharmacological approaches are indicated.
Although peripheral nerve decompression has been found to be effective in relieving some symptoms for burn patients, there is still some uncertainty.
Although evidence of cognitive impairment in MSA is admittedly more limited than in Parkinson disease, it is now substantial enough to address modification of diagnostic criteria to include the potential for cognitive impairment at any stage of the disease.
Neuraxial anesthetics and analgesics are associated with fewer systemic adverse effects.
Despite mounting evidence suggesting the contrary, the debate on the potential benefits of patent foramen ovale closure for migraine is still ongoing.
Evaluating the risk factors of neurocognitive decline in HIV.
Withholding negative research results not only skews scientific evidence but also puts into question the whole validity of medical research.
Ischemic and hemorrhagic strokes are a common complication of infective endocarditis, but guidance on intervention is varied.
Risk for mortality in posttraumatic epilepsy is high, and negative outcomes affecting cognitive, affective, and physical function are common.
Presport evaluations are a great opportunity to check in with players about their mental health, and to guide those who are suffering to the relevant specialist.
While parkinsonian disorders share a common mechanism of protein aggregation, manifestations are quite varied.
The 2 treatments for cluster headache with Level A recommendations are either not readily accessible via public or private insurance or are not recommended in a large subset of patients with cardiovascular disease.
Findings from animal studies indicate that anesthetics may be neurotoxic and could result in long-term central nervous system alterations and cognitive dysfunction.
Research has shown significant gaps in knowledge on palliative services among neurology residents, resulting in low referral rates.
Despite a recent study concluding that oxygen therapy for cluster headache is not cost-prohibitive, many private payers and Medicare and Medicaid do not cover the effective therapy. Matthew Robbins, MD, Stewart Tepper, MD, and others weigh in on the controversial decision.
John Stoffel, MD, Professor of Urology, Service Chief, and Associate Chair for Ambulatory Urology in the University of Michigan Department of Urology discusses the management of urinary retention in patients with MS.
There are guidelines that should be followed when treating patients with insomnia.
There is speculation that dystonia is the result of dysfunction occurring in either the cerebellum or basal ganglia or as a result of an abnormal interaction between the two.
Physicians must remember that they will be a business owner in addition to being a health care provider.
While several theories have evolved over the years, none have unequivocally provided robust evidence to fully explain the clinical spectrum of migraine.
MRI may be used to identify Parkinson disease biomarkers that can inform diagnosis, track disease progression, and elucidate the neurobiological underpinnings of symptoms.
Brief periods of oxygen deprivation to the brain have been shown to provide neuroprotective effects that reduce stroke infarct size and improve recovery times.
Assessments showed a 66% reduction in pain during the session and a 33% reduction in pain at the end of the session.
The main challenge is to determine when treating tardive dyskinesia with any pharmacological agent would provide a net benefit.
Nearly 10% of pediatric patients with migraine also experience various episodic syndromes. Drs Amy Gelfand and Diana Lebron weigh in on what to look for to help you achieve the right diagnosis.
Multidisciplinary treatment may consist of psychological support and physical or occupational therapy along with the medical care provided by the referring physician.
Nearly 10% of pediatric patients with migraine also experience various episodic syndromes involving gastrointestinal pain, vomiting, or vertigo.
Many in the medical field are wondering whether now may be the right time for medical malpractice reform.
Debate continues as to whether ocular tremor represents a clinical marker of Parkinson's disease or a compensatory movement related to other bodily tremors.
Woman with SLE complains of headache, confusion, and mild somnolence to the emergency department.
Catastrophizing makes pain more painful, makes it last longer, and makes pain much harder to treat.
Accountable Care Organizations (ACOs) are increasingly taking responsibility for health care management, record-keeping, and payment.
Putative pathogensis insights have grown tremendously in the past 10 years.
Doctors suggest that urban landscapes may be a cause for headaches.
While post-traumatic headache (PTH) often resolves within 3 months, a substantial number of patients experience chronic PTH.
Investigators identified a series of prodromal signs that appear anywhere from 1 to 18 years before a clinical diagnosis of SCA2.
There is up to a 4-fold increase in risk in people with a first-degree relative affected by migraines, and twin studies have demonstrated heritability of approximately 42%.
For survivors of nontraumatic cardiac arrest, brain injury becomes a major factor in disability and long-term survival.
New guidelines for progressive supranuclear palsy provide very specific and sensitive criteria that allow for identification of clinical features of the disease at much earlier stages.
A hostile medical litigation climate is one of the major problems with the existing malpractice insurance system, driving significant losses of access to quality health care.
Several mechanisms involving trigeminovascular activation are often proposed in the literature as mechanisms underlying nonhemorrhagic headache in patients with AVM.
Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.
A patient should be notified of the possibility of developing an ICD before initiating any dopaminergic treatment for PD, particularly dopamine agonists.
This year's annual meeting of the American Academy of Neurology takes place in Boston, MA from April 22-28, 2017.
As the population ages, and as both the incidence of diabetes and the survival rates after chemotherapy treatment increase, the number of patients with neuropathic pain is expected to rise.
The characteristics of migraine may change throughout a woman's reproductive stages, and may require different treatment strategies.
The main objection to nonreporting of negative results is that it contributes to a body of knowledge that is at best, incomplete, and at worst, wrong.
The transition process can be challenging for patients and families, requiring a great deal of preplanning by providers.
The International League Against Epilepsy has revised its epilepsy classification system in an effort to inform epilepsy research and aid drug development.
The large number of recalls of medical devices has pointed to a need for more active monitoring of product performance from the standpoints of both safety and efficacy.
New evidence on diabetic neuropathy has emerged since the ADA's last published a position statement in 2005.
Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.
There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.
Female athletes face a greater incidence of and longer recovery time from concussion compared with males.
Comorbid psychological conditions affect cognitive function in Parkinson's disease, and treatment can be complicated by overlapping symptoms.
The National Academies of Sciences, Engineering, and Medicine have released a report
The new guidelines offer guidance on dosing, including reduced starting and maintenance dosing and safety precautions for diagnosing and treating complications.
Functional MRI may provide a less-invasive option for evaluating memory function in patients undergoing epilepsy surgery.
The review found that there is substantial evidence that supports folic acid supplementation during pregnancy.
Keeping abreast of changing payment models and regulations is key to maximizing your practice's finances.
SPECT imaging can be more accurate in the diagnosis of traumatic brain injury and post-traumatic stress disorder than CT or MRI.
The guidelines were developed by a group of RLS experts from the US and Europe who utilized the American Academy of Neurology's 2004 guideline development manual.
Recovery time varies depending on which class of medication the patient is overusing.
Learn about the key scientific sessions taking place at CNS 2016 and follow along with Neurology Advisor for full meeting coverage.
Acupuncture, neurostimulation, and other alternative treatments have been associated with up to a 50% reduction in headache days.
Neuroimaging and if necessary, genetic testing, can help to confirm an FTD diagnosis.
The 4th World Parkinson Congress takes September 20-23, 2016 in Portland, Oregon.
A proper MS diagnosis can only be made after obtaining imaging from the entire brain and understanding the clinical context.
The new guidelines include a step-by-step diagnostic algorithm for use in the clinical setting, as well as a special emphasis on neurobehavioral impairment.
Neurologists should collaborate with other specialties in order to increase awareness of migraine prevalence in men.
It has been proposed that the gut microbiome may be an important environmental risk factor in MS.
Myoclonic seizures may be easily mistaken for a possible tic disorder if the proper patient monitoring is not conducted during diagnosis.
It's important for pediatric neurologists to spend time preparing the patient for the transition to adult care.
According to a 2010 report based on a survey of caregivers of people with DLB, 78% of cases were initially misdiagnosed.
Medication, plus a relatively sedentary lifestyle, places people with epilepsy at great risk of metabolic syndrome and its various complications.
While supplementation has produced a positive response in disease activity, adverse events based on dosing are concerning.
The guidelines are the result of a consensus of an international task force of MG experts.
One of the biggest hurdles is getting the patient to be honest and open with you about bladder problems.
Neurology Advisor Articles
- Updated Ischemic Stroke Guidelines: Expert Takeaways
- Alternative Genetic Risk Variant for Alzheimer Disease Identified
- Advance Directives for Dementia: Honoring Patient Wishes When You Don't Know What They Are
- Ethical Considerations in New Coma Research
- Poor Sleep Associated With Worse PTSD, Chronic Pain in Youth
- Comparing Reference Points for Deep Brain Stimulation Location in Parkinson Disease
- FDA Approves Clinical Decision Support Tool for Stroke
- US Will Produce Radioisotope for MRI, FDA Says
- Cognitive Decline in Men Linked to Low Serum Sodium
- Solanezumab Every 4 Weeks Does Not Significantly Affect Cognitive Decline in Alzheimer Disease